Aua Capital Management, LLC Meridian Bioscience Inc Transaction History

Aua Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$23.75 - $31.69 $166 - $221	7 Added 30.43%	30 $1,000
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $157 - $194	9 Added 64.29%	23 $0
Q3 2021 Nov 09, 2021	SELL	$17.35 - $22.5 $1,526 - $1,980	-88 Reduced 86.27%	14 $0
Q2 2021 Jul 29, 2021	SELL	$18.01 - $28.32 $126 - $198	-7 Reduced 6.42%	102 $2,000
Q4 2020 Feb 09, 2021	BUY	$15.73 - $21.66 $377 - $519	24 Added 28.24%	109 $2,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $1,150 - $2,244	85 New	85 $1,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.